CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

Published:2020-11 Issue:11 Volume:28 Page:2320-2339
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Wagner Jessica,Wickman Elizabeth,DeRenzo Christopher,Gottschalk Stephen

Funder

Alex's Lemonade Stand Foundation for Childhood Cancer

American Lebanese Syrian Associated Charities

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference289 articles.

1. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;N. Engl. J. Med.,2011

2. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N. Engl. J. Med.,2013

3. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

4. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy;Fry;Nat. Med.,2018

5. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults;Gardner;Blood,2017

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling;Translational Oncology;2024-11

2. Mesenchymal Stem Cells Target Gastric Cancer and Deliver Epirubicin via Tunneling Nanotubes for Enhanced Chemotherapy;Current Stem Cell Research & Therapy;2024-11

3. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

4. Ecological and evolutionary dynamics to design and improve ovarian cancer treatment;Clinical and Translational Medicine;2024-08-29

5. Generation of Murine Chimeric Antigen Receptor‐Modified T Cells for In Vivo Studies in Syngeneic Tumor Models;Current Protocols;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3